MP-AzeFlu Allergen Chamber - Onset of Action Study

Summary

This study is to assess the onset of action of fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray (MP-AzeFlu) in treating the nasal symptoms of seasonal allergic rhinitis (SAR) induced by an allergen challenge in an Environmental Exposure Chamber (EEC).

Timeline

Start

2017-01-07

Primary completion

2017-03-29

Completion

2017-03-29

Drugs

Indications